EBAY INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EBAY INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $17.90B | Feb 6, 2015 |
| FY2014 | Dec 31, 2013 | $16.05B | Feb 6, 2015 |
| FY2014 | Dec 31, 2012 | $14.07B | Feb 6, 2015 |
| FY2013 | Dec 31, 2011 | $11.65B | Jan 31, 2014 |
| FY2012 | Dec 31, 2010 | $9.16B | Feb 1, 2013 |
| FY2011 | Dec 31, 2009 | $8.73B | Jan 31, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.10B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $10.28B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $10.11B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $9.80B | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $2.61B | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $2.50B | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $2.67B | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $2.64B | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $2.48B | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $2.26B | Feb 24, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.61B | Feb 5, 2018 |
| FY2017 | Sep 30, 2017 | $2.41B | Feb 5, 2018 |
| FY2017 | Jun 30, 2017 | $2.33B | Feb 5, 2018 |
| FY2017 | Mar 31, 2017 | $2.22B | Feb 5, 2018 |
| FY2017 | Dec 31, 2016 | $2.40B | Feb 5, 2018 |
| FY2017 | Sep 30, 2016 | $2.22B | Feb 5, 2018 |
| FY2017 | Jun 30, 2016 | $2.23B | Feb 5, 2018 |
| FY2017 | Mar 31, 2016 | $2.14B | Feb 5, 2018 |
| FY2016 | Dec 31, 2015 | $2.32B | Feb 6, 2017 |
| FY2016 | Sep 30, 2015 | $2.10B | Feb 6, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.93B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $7.40B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $7.28B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $7.12B | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $1.92B | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $1.82B | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $2.00B | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $2.03B | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $1.93B | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $1.78B | Feb 24, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.03B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.98B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.77B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($1.27B) | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $1.97B | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $264.00M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $10.73B | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $641.00M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $845.00M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $664.00M | Feb 24, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.28B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.32B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.94B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.35B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.92B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $2.64B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.77B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.75B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $2.26B | Jan 31, 2020 |
| FY2018 | Dec 31, 2016 | $2.33B | Jan 30, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.48B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.54B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.33B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.33B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.03B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $930.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.05B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $1.22B | Jan 31, 2020 |
| FY2018 | Dec 31, 2016 | $1.11B | Jan 30, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.96B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.41B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.43B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.25B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.66B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $2.42B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $3.11B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $2.66B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $3.15B | Jan 31, 2020 |
| FY2018 | Dec 31, 2016 | $2.83B | Jan 30, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $525.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $458.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $456.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $449.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $444.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $463.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $508.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $623.00M | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $666.00M | Jan 31, 2020 |
| FY2018 | Dec 31, 2016 | $626.00M | Jan 30, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.61B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $19.37B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $21.62B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $20.85B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $26.63B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $19.31B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $18.17B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $22.82B | Jan 31, 2020 |
| FY2018 | Dec 31, 2017 | $25.99B | Jan 30, 2019 |
| FY2017 | Dec 31, 2016 | $23.85B | Feb 5, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.00B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $14.21B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $15.22B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $15.70B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $16.85B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $15.75B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $15.30B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $16.54B | Jan 31, 2020 |
| FY2018 | Dec 31, 2017 | $17.94B | Jan 30, 2019 |
| FY2017 | Dec 31, 2016 | $13.31B | Feb 5, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.62B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $5.16B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $6.40B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $5.15B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $9.78B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $3.56B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.87B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $6.28B | Feb 4, 2021 |
| FY2019 | Dec 31, 2017 | $8.05B | Jan 31, 2020 |
| FY2018 | Dec 31, 2016 | $10.53B | Jan 30, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.47B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $4.27B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $4.27B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $4.26B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $4.18B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $4.29B | Feb 23, 2023 |
| FY2020 | Dec 31, 2019 | $4.53B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $5.16B | Jan 31, 2020 |
| FY2019 | Dec 31, 2017 | $4.77B | Jan 31, 2020 |
| FY2018 | Dec 31, 2016 | $4.50B | Jan 30, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.43B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $37.95B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $36.53B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $34.32B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $36.09B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $22.96B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $17.75B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $16.46B | Jan 31, 2020 |
| FY2018 | Dec 31, 2017 | $13.93B | Jan 30, 2019 |
| FY2017 | Dec 31, 2016 | $14.96B | Feb 5, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.87B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.43B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.99B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.15B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.38B | Feb 28, 2024 |
| FY2021 | Dec 31, 2020 | $1.10B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $901.00M | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $2.20B | Jan 31, 2020 |
| FY2018 | Dec 31, 2017 | $2.12B | Jan 30, 2019 |
| FY2017 | Dec 31, 2016 | $1.82B | Feb 5, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $7.72B | Feb 23, 2023 |
| FY2022 | Dec 31, 2021 | $7.73B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.74B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $6.74B | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | $7.69B | Jan 31, 2020 |
| FY2018 | Dec 31, 2017 | $9.23B | Jan 30, 2019 |
| FY2017 | Dec 31, 2016 | $7.51B | Feb 5, 2018 |
| FY2016 | Dec 31, 2015 | $6.75B | Feb 6, 2017 |
| FY2014 | Dec 31, 2014 | $7.60B | Feb 6, 2015 |
| FY2013 | Dec 31, 2013 | $4.12B | Jan 31, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | 3 | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | 15 | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 1 | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 24, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | 3 | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | 15 | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 1 | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 24, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 449.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 471.00M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 517.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 539.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 594.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 684.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 796.00M | Feb 4, 2021 |
| FY2019 | Dec 31, 2018 | 915.00M | Jan 31, 2020 |
| FY2018 | Dec 31, 2017 | 1.03B | Jan 30, 2019 |
| FY2017 | Dec 31, 2016 | 1.09B | Feb 5, 2018 |